APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol and Ciprofol Injections

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol and Ciprofol Injections Market Outlook and Growth Opportunities 2026

22 December 2025204 pages

Choose your research edition.

Industry ResearchPropofol and Ciprofol Injections Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol and Ciprofol Injections Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Propofol and Ciprofol Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol and Ciprofol Injections Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol and Ciprofol Injections Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Propofol and Ciprofol Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol and Ciprofol Injections market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol and Ciprofol Injections market include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Haisco Pharmaceutical Group, Jiangsu Yingke Biopharmaceutical, Pfizer, Guangdong Jiabo Pharmaceutical, Fresenius Kabi, Jiangsu Nhwa Pharmaceutical and B. Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol and Ciprofol Injections market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol and Ciprofol Injections and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol and Ciprofol Injections sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol and Ciprofol Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol and Ciprofol Injections Segment by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Haisco Pharmaceutical Group

Jiangsu Yingke Biopharmaceutical

Pfizer

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Jiangsu Nhwa Pharmaceutical

B. Braun

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

AstraZeneca

Wellona Pharma

Rusoma

NEON

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

Propofol and Ciprofol Injections Segment by Type

Propofol Injections

Ciprofol Injections

Propofol and Ciprofol Injections Segment by Application

Gastrointestinal Endoscopy

Anesthesia for Surgery

Other

Propofol and Ciprofol Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Propofol and Ciprofol Injections status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Propofol and Ciprofol Injections market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol and Ciprofol Injections significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol and Ciprofol Injections competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol and Ciprofol Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol and Ciprofol Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol and Ciprofol Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol and Ciprofol Injections market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol and Ciprofol Injections industry.

Chapter 3: Detailed analysis of Propofol and Ciprofol Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Propofol and Ciprofol Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Propofol and Ciprofol Injections in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol and Ciprofol Injections Industry Trends Table 2. Propofol and Ciprofol Injections Industry Drivers Table 3. Propofol and Ciprofol Injections Industry Opportunities and Challenges Table 4. Propofol and Ciprofol Injections Industry Restraints Table 5. Global Propofol and Ciprofol Injections Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol and Ciprofol Injections Revenue Share by Company (2021-2026) Table 7. Global Propofol and Ciprofol Injections Sales Volume by Company (k units) & (2021-2026) Table 8. Global Propofol and Ciprofol Injections Sales Volume Share by Company (2021-2026) Table 9. Global Propofol and Ciprofol Injections Average Price (US$/unit) of Company (2021-2026) Table 10. Global Propofol and Ciprofol Injections Company Ranking, (2024-2026) & (USD Million) Table 11. Global Propofol and Ciprofol Injections Key Company Manufacturing Base & Headquarters Table 12. Global Propofol and Ciprofol Injections Company, Product Type & Application Table 13. Global Propofol and Ciprofol Injections Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol and Ciprofol Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Propofol Injections Table 18. Significant Companies of Ciprofol Injections Table 19. Global Propofol and Ciprofol Injections Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Propofol and Ciprofol Injections Sales Volume by Type (2021-2026) & (k units) Table 21. Global Propofol and Ciprofol Injections Sales Volume by Type (2027-2032) & (k units) Table 22. Global Propofol and Ciprofol Injections Sales Volume Share by Type (2021-2026) Table 23. Global Propofol and Ciprofol Injections Sales Volume Share by Type (2027-2032) Table 24. Global Propofol and Ciprofol Injections Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Propofol and Ciprofol Injections Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Propofol and Ciprofol Injections Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Propofol and Ciprofol Injections Sales Value Share by Type (2021-2026) Table 28. Global Propofol and Ciprofol Injections Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Gastrointestinal Endoscopy Table 30. Significant Companies of Anesthesia for Surgery Table 31. Significant Companies of Other Table 32. Global Propofol and Ciprofol Injections Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Propofol and Ciprofol Injections Sales Volume by Application (2021-2026) & (k units) Table 34. Global Propofol and Ciprofol Injections Sales Volume by Application (2027-2032) & (k units) Table 35. Global Propofol and Ciprofol Injections Sales Volume Share by Application (2021-2026) Table 36. Global Propofol and Ciprofol Injections Sales Volume Share by Application (2027-2032) Table 37. Global Propofol and Ciprofol Injections Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Propofol and Ciprofol Injections Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Propofol and Ciprofol Injections Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Propofol and Ciprofol Injections Sales Value Share by Application (2021-2026) Table 41. Global Propofol and Ciprofol Injections Sales Value Share by Application (2027-2032) Table 42. Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Propofol and Ciprofol Injections Sales by Region (2021-2026) & (k units) Table 44. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026) Table 45. Global Propofol and Ciprofol Injections Sales by Region (2027-2032) & (k units) Table 46. Global Propofol and Ciprofol Injections Sales Market Share by Region (2027-2032) Table 47. Global Propofol and Ciprofol Injections Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Propofol and Ciprofol Injections Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Propofol and Ciprofol Injections Sales Value Share by Region (2021-2026) Table 50. Global Propofol and Ciprofol Injections Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Propofol and Ciprofol Injections Sales Value Share by Region (2027-2032) Table 52. Global Propofol and Ciprofol Injections Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Propofol and Ciprofol Injections Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Propofol and Ciprofol Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Propofol and Ciprofol Injections Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 57. Global Propofol and Ciprofol Injections Sales Market Share by Country (2021-2026) Table 58. Global Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 59. Global Propofol and Ciprofol Injections Sales Market Share by Country (2027-2032) Table 60. Global Propofol and Ciprofol Injections Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Propofol and Ciprofol Injections Sales Value Market Share by Country (2021-2026) Table 62. Global Propofol and Ciprofol Injections Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Propofol and Ciprofol Injections Sales Value Market Share by Country (2027-2032) Table 64. Xi’an Libang Pharmaceutical Company Information Table 65. Xi’an Libang Pharmaceutical Business Overview Table 66. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 68. Xi’an Libang Pharmaceutical Recent Development Table 69. Sichuan Kelun Pharmaceutical Company Information Table 70. Sichuan Kelun Pharmaceutical Business Overview Table 71. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 73. Sichuan Kelun Pharmaceutical Recent Development Table 74. Haisco Pharmaceutical Group Company Information Table 75. Haisco Pharmaceutical Group Business Overview Table 76. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio Table 78. Haisco Pharmaceutical Group Recent Development Table 79. Jiangsu Yingke Biopharmaceutical Company Information Table 80. Jiangsu Yingke Biopharmaceutical Business Overview Table 81. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 83. Jiangsu Yingke Biopharmaceutical Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Propofol and Ciprofol Injections Product Portfolio Table 88. Pfizer Recent Development Table 89. Guangdong Jiabo Pharmaceutical Company Information Table 90. Guangdong Jiabo Pharmaceutical Business Overview Table 91. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 93. Guangdong Jiabo Pharmaceutical Recent Development Table 94. Fresenius Kabi Company Information Table 95. Fresenius Kabi Business Overview Table 96. Fresenius Kabi Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio Table 98. Fresenius Kabi Recent Development Table 99. Jiangsu Nhwa Pharmaceutical Company Information Table 100. Jiangsu Nhwa Pharmaceutical Business Overview Table 101. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 103. Jiangsu Nhwa Pharmaceutical Recent Development Table 104. B. Braun Company Information Table 105. B. Braun Business Overview Table 106. B. Braun Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. B. Braun Propofol and Ciprofol Injections Product Portfolio Table 108. B. Braun Recent Development Table 109. Beijing Sciecure Pharmaceutical Company Information Table 110. Beijing Sciecure Pharmaceutical Business Overview Table 111. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 113. Beijing Sciecure Pharmaceutical Recent Development Table 114. Sichuan Biokin Pharmaceutical Company Information Table 115. Sichuan Biokin Pharmaceutical Business Overview Table 116. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 118. Sichuan Biokin Pharmaceutical Recent Development Table 119. AstraZeneca Company Information Table 120. AstraZeneca Business Overview Table 121. AstraZeneca Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. AstraZeneca Propofol and Ciprofol Injections Product Portfolio Table 123. AstraZeneca Recent Development Table 124. Wellona Pharma Company Information Table 125. Wellona Pharma Business Overview Table 126. Wellona Pharma Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Wellona Pharma Propofol and Ciprofol Injections Product Portfolio Table 128. Wellona Pharma Recent Development Table 129. Rusoma Company Information Table 130. Rusoma Business Overview Table 131. Rusoma Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Rusoma Propofol and Ciprofol Injections Product Portfolio Table 133. Rusoma Recent Development Table 134. NEON Company Information Table 135. NEON Business Overview Table 136. NEON Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. NEON Propofol and Ciprofol Injections Product Portfolio Table 138. NEON Recent Development Table 139. Flagship Biotech Company Information Table 140. Flagship Biotech Business Overview Table 141. Flagship Biotech Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Flagship Biotech Propofol and Ciprofol Injections Product Portfolio Table 143. Flagship Biotech Recent Development Table 144. Dr. Reddy's Laboratories Company Information Table 145. Dr. Reddy's Laboratories Business Overview Table 146. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio Table 148. Dr. Reddy's Laboratories Recent Development Table 149. Centurion Healthcare Company Information Table 150. Centurion Healthcare Business Overview Table 151. Centurion Healthcare Propofol and Ciprofol Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio Table 153. Centurion Healthcare Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Propofol and Ciprofol Injections Distributors List Table 157. Propofol and Ciprofol Injections Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Propofol and Ciprofol Injections Product Image Figure 2. Global Propofol and Ciprofol Injections Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 4. Global Propofol and Ciprofol Injections Sales (2021-2032) & (k units) Figure 5. Global Propofol and Ciprofol Injections Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Propofol and Ciprofol Injections Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Propofol Injections Image Figure 10. Ciprofol Injections Image Figure 11. Global Propofol and Ciprofol Injections Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Propofol and Ciprofol Injections Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Propofol and Ciprofol Injections Sales Volume Share by Type (2021-2032) Figure 14. Global Propofol and Ciprofol Injections Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Propofol and Ciprofol Injections Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Propofol and Ciprofol Injections Sales Value Share by Type (2021-2032) Figure 17. Gastrointestinal Endoscopy Image Figure 18. Anesthesia for Surgery Image Figure 19. Other Image Figure 20. Global Propofol and Ciprofol Injections Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Propofol and Ciprofol Injections Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Propofol and Ciprofol Injections Sales Volume Share by Application (2021-2032) Figure 23. Global Propofol and Ciprofol Injections Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Propofol and Ciprofol Injections Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Propofol and Ciprofol Injections Sales Value Share by Application (2021-2032) Figure 26. Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Propofol and Ciprofol Injections Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Propofol and Ciprofol Injections Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Propofol and Ciprofol Injections Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 31. North America Propofol and Ciprofol Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Propofol and Ciprofol Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Propofol and Ciprofol Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 37. South America Propofol and Ciprofol Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Propofol and Ciprofol Injections Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Propofol and Ciprofol Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Propofol and Ciprofol Injections Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Propofol and Ciprofol Injections Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol Injections
  • Ciprofol Injections
Applications
  • Gastrointestinal Endoscopy
  • Anesthesia for Surgery
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Haisco Pharmaceutical Group
  • Jiangsu Yingke Biopharmaceutical
  • Pfizer
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Jiangsu Nhwa Pharmaceutical
  • B. Braun
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • AstraZeneca
  • Wellona Pharma
  • Rusoma
  • NEON
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propofol and Ciprofol Injections Sales Value (2021-2032)
  4. 1.2.2 Global Propofol and Ciprofol Injections Sales Volume (2021-2032)
  5. 1.2.3 Global Propofol and Ciprofol Injections Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Propofol and Ciprofol Injections Market Dynamics
  1. 2.1 Propofol and Ciprofol Injections Industry Trends
  2. 2.2 Propofol and Ciprofol Injections Industry Drivers
  3. 2.3 Propofol and Ciprofol Injections Industry Opportunities and Challenges
  4. 2.4 Propofol and Ciprofol Injections Industry Restraints
3 Propofol and Ciprofol Injections Market by Company
  1. 3.1 Global Propofol and Ciprofol Injections Company Revenue Ranking in 2025
  2. 3.2 Global Propofol and Ciprofol Injections Revenue by Company (2021-2026)
  3. 3.3 Global Propofol and Ciprofol Injections Sales Volume by Company (2021-2026)
  4. 3.4 Global Propofol and Ciprofol Injections Average Price by Company (2021-2026)
  5. 3.5 Global Propofol and Ciprofol Injections Company Ranking (2024-2026)
  6. 3.6 Global Propofol and Ciprofol Injections Company Manufacturing Base and Headquarters
  7. 3.7 Global Propofol and Ciprofol Injections Company Product Type and Application
  8. 3.8 Global Propofol and Ciprofol Injections Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Propofol and Ciprofol Injections Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Propofol and Ciprofol Injections Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Propofol and Ciprofol Injections Market by Type
  1. 4.1 Propofol and Ciprofol Injections Type Introduction
  2. 4.1.1 Propofol Injections
  3. 4.1.2 Ciprofol Injections
  4. 4.2 Global Propofol and Ciprofol Injections Sales Volume by Type
  5. 4.2.1 Global Propofol and Ciprofol Injections Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Propofol and Ciprofol Injections Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Propofol and Ciprofol Injections Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Propofol and Ciprofol Injections Sales Value by Type
  9. 4.3.1 Global Propofol and Ciprofol Injections Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Propofol and Ciprofol Injections Sales Value by Type (2021-2032)
  11. 4.3.3 Global Propofol and Ciprofol Injections Sales Value Share by Type (2021-2032)
5 Propofol and Ciprofol Injections Market by Application
  1. 5.1 Propofol and Ciprofol Injections Application Introduction
  2. 5.1.1 Gastrointestinal Endoscopy
  3. 5.1.2 Anesthesia for Surgery
  4. 5.1.3 Other
  5. 5.2 Global Propofol and Ciprofol Injections Sales Volume by Application
  6. 5.2.1 Global Propofol and Ciprofol Injections Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol and Ciprofol Injections Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Propofol and Ciprofol Injections Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Propofol and Ciprofol Injections Sales Value by Application
  10. 5.3.1 Global Propofol and Ciprofol Injections Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol and Ciprofol Injections Sales Value by Application (2021-2032)
  12. 5.3.3 Global Propofol and Ciprofol Injections Sales Value Share by Application (2021-2032)
6 Propofol and Ciprofol Injections Regional Sales and Value Analysis
  1. 6.1 Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol and Ciprofol Injections Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol and Ciprofol Injections Sales by Region: 2021-2026
  4. 6.2.2 Global Propofol and Ciprofol Injections Sales by Region (2027-2032)
  5. 6.3 Global Propofol and Ciprofol Injections Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Propofol and Ciprofol Injections Sales Value by Region (2021-2032)
  7. 6.4.1 Global Propofol and Ciprofol Injections Sales Value by Region: 2021-2026
  8. 6.4.2 Global Propofol and Ciprofol Injections Sales Value by Region (2027-2032)
  9. 6.5 Global Propofol and Ciprofol Injections Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Propofol and Ciprofol Injections Sales Value (2021-2032)
  12. 6.6.2 North America Propofol and Ciprofol Injections Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Propofol and Ciprofol Injections Sales Value (2021-2032)
  15. 6.7.2 Europe Propofol and Ciprofol Injections Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Propofol and Ciprofol Injections Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Propofol and Ciprofol Injections Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Propofol and Ciprofol Injections Sales Value (2021-2032)
  21. 6.9.2 South America Propofol and Ciprofol Injections Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Propofol and Ciprofol Injections Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Propofol and Ciprofol Injections Sales Value Share by Country, 2025 VS 2032
7 Propofol and Ciprofol Injections Country-level Sales and Value Analysis
  1. 7.1 Global Propofol and Ciprofol Injections Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol and Ciprofol Injections Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Propofol and Ciprofol Injections Sales by Country (2021-2032)
  4. 7.3.1 Global Propofol and Ciprofol Injections Sales by Country (2021-2026)
  5. 7.3.2 Global Propofol and Ciprofol Injections Sales by Country (2027-2032)
  6. 7.4 Global Propofol and Ciprofol Injections Sales Value by Country (2021-2032)
  7. 7.4.1 Global Propofol and Ciprofol Injections Sales Value by Country (2021-2026)
  8. 7.4.2 Global Propofol and Ciprofol Injections Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Propofol and Ciprofol Injections Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Propofol and Ciprofol Injections Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Propofol and Ciprofol Injections Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi’an Libang Pharmaceutical
  2. 8.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 8.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 8.1.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  6. 8.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical
  8. 8.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 8.3 Haisco Pharmaceutical Group
  14. 8.3.1 Haisco Pharmaceutical Group Company Information
  15. 8.3.2 Haisco Pharmaceutical Group Business Overview
  16. 8.3.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio
  18. 8.3.5 Haisco Pharmaceutical Group Recent Developments
  19. 8.4 Jiangsu Yingke Biopharmaceutical
  20. 8.4.1 Jiangsu Yingke Biopharmaceutical Company Information
  21. 8.4.2 Jiangsu Yingke Biopharmaceutical Business Overview
  22. 8.4.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio
  24. 8.4.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Propofol and Ciprofol Injections Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Guangdong Jiabo Pharmaceutical
  32. 8.6.1 Guangdong Jiabo Pharmaceutical Company Information
  33. 8.6.2 Guangdong Jiabo Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  36. 8.6.5 Guangdong Jiabo Pharmaceutical Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Jiangsu Nhwa Pharmaceutical
  44. 8.8.1 Jiangsu Nhwa Pharmaceutical Company Information
  45. 8.8.2 Jiangsu Nhwa Pharmaceutical Business Overview
  46. 8.8.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  48. 8.8.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  49. 8.9 B. Braun
  50. 8.9.1 B. Braun Company Information
  51. 8.9.2 B. Braun Business Overview
  52. 8.9.3 B. Braun Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Propofol and Ciprofol Injections Product Portfolio
  54. 8.9.5 B. Braun Recent Developments
  55. 8.10 Beijing Sciecure Pharmaceutical
  56. 8.10.1 Beijing Sciecure Pharmaceutical Company Information
  57. 8.10.2 Beijing Sciecure Pharmaceutical Business Overview
  58. 8.10.3 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  60. 8.10.5 Beijing Sciecure Pharmaceutical Recent Developments
  61. 8.11 Sichuan Biokin Pharmaceutical
  62. 8.11.1 Sichuan Biokin Pharmaceutical Company Information
  63. 8.11.2 Sichuan Biokin Pharmaceutical Business Overview
  64. 8.11.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  66. 8.11.5 Sichuan Biokin Pharmaceutical Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Propofol and Ciprofol Injections Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Wellona Pharma
  74. 8.13.1 Wellona Pharma Company Information
  75. 8.13.2 Wellona Pharma Business Overview
  76. 8.13.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Wellona Pharma Propofol and Ciprofol Injections Product Portfolio
  78. 8.13.5 Wellona Pharma Recent Developments
  79. 8.14 Rusoma
  80. 8.14.1 Rusoma Company Information
  81. 8.14.2 Rusoma Business Overview
  82. 8.14.3 Rusoma Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Rusoma Propofol and Ciprofol Injections Product Portfolio
  84. 8.14.5 Rusoma Recent Developments
  85. 8.15 NEON
  86. 8.15.1 NEON Company Information
  87. 8.15.2 NEON Business Overview
  88. 8.15.3 NEON Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 NEON Propofol and Ciprofol Injections Product Portfolio
  90. 8.15.5 NEON Recent Developments
  91. 8.16 Flagship Biotech
  92. 8.16.1 Flagship Biotech Company Information
  93. 8.16.2 Flagship Biotech Business Overview
  94. 8.16.3 Flagship Biotech Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Flagship Biotech Propofol and Ciprofol Injections Product Portfolio
  96. 8.16.5 Flagship Biotech Recent Developments
  97. 8.17 Dr. Reddy's Laboratories
  98. 8.17.1 Dr. Reddy's Laboratories Company Information
  99. 8.17.2 Dr. Reddy's Laboratories Business Overview
  100. 8.17.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio
  102. 8.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 8.18 Centurion Healthcare
  104. 8.18.1 Centurion Healthcare Company Information
  105. 8.18.2 Centurion Healthcare Business Overview
  106. 8.18.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio
  108. 8.18.5 Centurion Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol and Ciprofol Injections Value Chain Analysis
  2. 9.1.1 Propofol and Ciprofol Injections Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol and Ciprofol Injections Sales Mode & Process
  6. 9.2 Propofol and Ciprofol Injections Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol and Ciprofol Injections Distributors
  9. 9.2.3 Propofol and Ciprofol Injections Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst